Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Mol. Cell Biochem., 2016, 414:77-84; DOI 10.1007/s11010-016-2660-y | ||
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Inc. J. Biochem. Mol. Toxicol., 2014, 28 :394-399, DOI 10.1002/jbt.21576 | ||
WS-15 |
Human breast cancer cell line | Human | breast | cell line | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | |||
WM853 |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | ||
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liang et al., Experimantal and Therapeutic Medicine, 2017, 14: 2367-2372, DOI: 10.3892/etm.2017.4779 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liu et al., Pathology - Res. and Practice, 2019, 215, 152641, doi.org/10.1016/j.prp.2019.152641 | Link | |
UMel-2 |
Human primary ciliry body melanoma cells | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
UACC-257 |
Human melanoma cells | Human | skin | unknown | adherent | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
|||
UACC-257 |
Human melanoma cells | Human | skin | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
U937 |
Human histiocytic lymphoma cell line | ATCC CRL-1593.2 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Innate Immunity, Nov 2014; 20: 799 - 815. | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., Jul 2015; 290: 17894 - 17908 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | B. Li et al., ResearchSquare, 2020, doi.org/10.21203/rs.3.rs-58864/v1 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | G. Eisele et al., Neuro Oncology, Feb 2011; 13: 155 - 164 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
U2OS 2-6-3 |
Human bone osteosarcoma cell line (derivat of U2OS) | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Hernández-Pérez et al., Oncogene, 2017, 36: 4802-4809, doi:10.1038/onc.2017.21 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Martin et al., Oncogene, 2015, 34:1058-1063; doi:10.1038/onc.2014.38 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz et al., Hum. Mol. Genet., Dec 2016, DOI: 10.1093/hmg/ddw364 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Di Maio et al., FEBS Open Bio, 2017, 7: 1453-1468, doi:10.1002/2211-5463.12307 | Link |